Worldwide Radiopharmaceutical Industry to 2025 – Use of Radiopharmaceuticals In Neurological Applications Presents Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Radiopharmaceutical Market (2020-2025) by Type, Application, Procedure, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.
The Global Radiopharmaceuticals Market is estimated to be USD 6.3 Bn in 2020 and is expected to reach USD 7.9 Bn by 2025, growing at a CAGR of 4.5%.
Factors such as high demand for nuclear medicine such as SPECT and PET scan towards the diagnosis of diseases like cancer and other chronic diseases and increasing patient awareness for accuracy in the diagnosis have led to being a major driver of growth for this market. An increase in the prevalence of cancer and increased use of medical imaging as a diagnostics procedure is fuelling the growth of the market.
The high cost of developing radiopharmaceuticals relative to the return on investment, stringent regulatory requirements are restraining the growth of the radiopharmaceuticals market. The increase in R&D activities with technological advancement and strategic partnerships in the market are expected to create ample opportunities in the radiopharmaceuticals market.
Market Dynamics
Drivers
- High Demand for Early Diagnosis in the Event of Cancer and Cardiovascular Chronic Diseases
- Rising Healthcare Expenditure
- Alpha Radio-Immunotherapy-Based Targeted Cancer Treatment
- Initiatives to Lessen The Demand-Supply Gap of Isotopes
Restraints
- Stringent Regulatory Guidelines
- The High Cost of Devices Using Radioisotopes
- The Short Half-Life of Radiopharmaceuticals
Opportunities
- Use of Radiopharmaceuticals In Neurological Applications
- Growing Awareness about the Benefits of Radiopharmaceuticals amongst Healthcare Providers
- Technological Advancements
Challenges
- Hospital Budget Cuts and High Equipment Prices
Trends
- Increasing Preference of Spect and Pet Scans
Why buy this report?
- The report offers a comprehensive evaluation of the Global Radiopharmaceuticals Market.
- The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
- The report also contains a competitive analysis using Positioning Quadrants, a Proprietary competitive positioning tool.
Report Highlights:
- A complete analysis of the market including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Companies Mentioned
- GE Healthcare
- Eckert & Ziegler Group
- Jubilant Life Sciences
- Mallinckrodt Pharmaceuticals
- Bracco Imaging S.p.A
- Nordion, Inc
- NTP Radioisotopes SOC Ltd.
- Cardinal Health
- Curium
- Bayer
- Lantheus Medical Imaging
- The Institute of Radioelements
- Australian Nuclear Science & Technology Organization
- Eczacibasi-Monrol
- Advanced Accelerator Applications S.A
- IBA Molecular Imaging
For more information about this report visit https://www.researchandmarkets.com/r/fuxg75
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
